Open in App
  • Local
  • Headlines
  • Election
  • Crime Map
  • Sports
  • Lifestyle
  • Education
  • Real Estate
  • Newsletter
  • targetedonc.com

    KEYNOTE-522 Trial: Pembrolizumab Boosts Survival in Early TNBC

    By Peter Schmid, MD, PhD,

    2 days ago
    Comments /
    Add a Comment
    YOU MAY ALSO LIKE
    Local News newsLocal News
    Herbie J Pilato20 days ago

    Comments / 0